About SRH Zentralklinikum Suhl
Das gemeinnützige SRH Zentralklinikum Suhl ist ein Akutkrankenhaus in Südthüringen mit 24 eigenständigen Fach- und Teilgebieten der Medizin und 519 Planbetten mit überregionalem Versorgungsauftrag. 2017 wurden 80.650 Patienten ambulant und 33.965 stationär behandelt.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Biotronik SE & Co. KG
2
A. M. Zeiher
1
AGO Research GmbH
1
Biotronik AG
1
Boston Scientific Corporation
1
Center for Sepsis Control and Care, Germany
1
ETOP IBCSG Partners Foundation
1
Eli Lilly and Company
1
German Breast Group
1
IHF GmbH - Institut für Herzinfarktforschung
1
Institut für Klinisch-Kardiovaskuläre Forschung GmbH
1
Clinical Trials at SRH Zentralklinikum Suhl
During the past decade, SRH Zentralklinikum Suhl conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
REPAIR-AMI: Intracoronary Progenitor Cells in Acute Myocardial Infarction (AMI)
2004-04-01
2010-12-01
Completed
204
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
2007-08-01
2019-05-15
Completed
4,884
Coronary Artery Disease and Renal Failure Registry
2007-12-01
2013-05-01
Unknown status
3,352
Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice
2010-03-01
2013-12-01
Completed
1,026
Medical Education for Sepsis Source Control and Antibiotics
2011-07-01
2013-07-01
Completed
4,138
BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction
2013-09-01
2019-11-27
Completed
375
Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-derived Mononuclear Cells on Mortality in Patients With Chronic Post-infarction Heart Failure
2013-11-01
2025-01-01
Active, not recruiting
81
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "SRH Zentralklinikum Suhl" #1 sponsor was "Biotronik SE & Co. KG" with 2 trials, followed by "A. M. Zeiher" with 1 trials
sponsored, "AGO Research GmbH" with 1 trials sponsored, "Biotronik AG" with 1 trials sponsored and "Boston Scientific Corporation"
with 1 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "SRH Zentralklinikum Suhl"
#1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at SRH Zentralklinikum Suhl
According to Clinical.Site data, the most researched conditions in "SRH Zentralklinikum Suhl" are
"Heart Failure" (3 trials), "Breast Neoplasms" (2 trials), "Myocardial Infarction" (2 trials), "Brain Ischemia With Non-valvular Atrial Fibrillation" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "SRH Zentralklinikum Suhl" in a lesser frequency.
Clinical Trials Intervention Types at SRH Zentralklinikum Suhl
Most popular intervention types in "SRH Zentralklinikum Suhl" are "Device" (6 trials), "Drug" (6 trials), "Biological" (3 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Letrozole" (2 trials), "ABSORB Scaffold" (1 trials), "Acticor/Rivacor ICDs/CRT-Ds" (1 trials) and "Anastrozole" (1 trials). Other intervention names were less common.
Clinical Trials Genders at SRH Zentralklinikum Suhl
The vast majority of trials in "SRH Zentralklinikum Suhl" are
15 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at SRH Zentralklinikum Suhl
Currently, there are NaN active trials in "SRH Zentralklinikum Suhl".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in SRH Zentralklinikum Suhl,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in SRH Zentralklinikum Suhl, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".